Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Energous Shares Charge 200% Higher After Receiving FCC Certification for Wireless Charging ...

Energous Shares Charge 200% Higher After Receiving FCC Certification for Wireless Charging Technology Shares of Energous Corp. skyrocketed after the company reported that it received certification from the FCC for its new, "groundbreaking" over-the-air, power-at-...
Streetwise Reports | April 22, 2020 |

AI & Humor in the Workplace … A Laughing Matter?

We have all worried about “robots taking our jobs”, but working in a creative field, I’ve always had a high-and-mighty belief that no mere machine could do what I do … until they could. Running a certain set of parameters through an ar...
According to published reports | September 1, 2021 |

RedHill Biopharma Shares Rise 10% After Receiving FDA Approval for H. Pylori Treatment Drug Talicia

Shares of RedHill Biopharma Ltd. traded more than 10% higher today after the firm announced that the FDA has approved its Talicia delayed-release capsules for the treatment of H. pylori infection in adults. The firm plans to commence distribution by its U.S. sales force in Q1/...
Streetwise Reports | November 5, 2019 |

Buzz on the Bullboards: Top Names in Mining, Cannabis, & Industrial Stocks

Having received UL 2723 ECOLOGO Certification for Mineral Exploration Companies last week, Critical Elements Lithium Corporation ( TSX-V: CRE , Forum ) announced this week that it had retained the services of Metso Outotec and WSP in Canada (WSP) to prepare a Pha...
Stockhouse Editorial | June 10, 2021 |

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...
Streetwise Reports | May 28, 2020 |

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...
Knox Henderson | December 23, 2024 |

Marijuana: Up in Smoke

Some younger folk might not know the Cheech and Chong movie, Up in Smoke . It was a 1978 stoner comedy that received mixed to negative reviews at the time. Nevertheless it was a success and is now considered a classic. As I remember it was about a couple of bumbling st...
Streetwise Reports | March 14, 2019 |

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

ProMIS' preclinical treatment could possibly outshine Biogen's candidate. Finding an effective treatment for Alzheimer's disease has been elusive as many seemingly promising avenues of research did not prove out in clinical trials. Biogen Inc. (BIIB:NASDAQ) appeared...
Streetwise Reports | November 7, 2019 |

Interim Data Indicate Multiantigen Cell Therapy in Solid Tumors 'Just Might Work'

The immuno-oncology company's findings are reviewed in a ROTH Capital Partners report. In a July 22 research note, ROTH Capital Partners analyst Tony Butler reported that "encouraging data" from Marker Therapeutics Inc.'s (MRKR:NASDAQ) Phase I trial, TACTO...
Streetwise Reports | July 24, 2019 |

Gapping Rotation in SPY and News Based Rallies Are A Warning

As holiday trading sets up in the global markets, the SPY is starting to show signs of volatility and warning of a potential top by gapping as price attempts to trade sideways. This type of top formation, along with the fact that the overnight REPO facility continues to roil t...
Chris Vermeulen | December 13, 2019 |
1 2 3 4 5 6 7 8 9 10 ...